AKT1 and cancer: In particular, the T>A mutation in chr1:11169377, which resulted in a p.I2500F change on protein sequence, activates the PI3K–AKT–mTOR signalling pathway and causes mTOR complex 1 (mTORC1) signalling to be partially resistant to nutrient deprivation in cancer cells (Figure 4) (45).